Hints and tips:
Related Special Reports
...Patients must have their stem cells extracted from their bone marrow so their genes can be edited in a laboratory....
...He said chancellor Jeremy Hunt and the health department should address conflicts with the pharmaceutical industry over drug prices and hurdles to running clinical trials in the NHS....
...Grail is forecast to lose $670mn in 2023 as it funds the largest-ever clinical study of a multicancer detection test in the UK....
...The clinical trial forms part of a six-year collaboration between Merck and Moderna in the field of developing personalised cancer vaccines....
...A smaller 30 microgram dose of the same vaccine boosted antibodies levels 13.5-fold, according to a clinical study of 1,234 participants aged 56 years or older....
...The algorithm could help replace or enhance painstaking laboratory work to identify the structures of proteins, which dictate how they behave....
...The companies said they were evaluating the vaccine against other strains, including one that first emerged in Brazil, and were conducting studies to monitor the vaccine’s effectiveness outside of the laboratory...
...Covid-19 vaccines from Moderna and BioNTech/Pfizer have been shown to work against the B.1.1.7 variant in laboratory tests....
...Members of the American Clinical Laboratory Association processed nearly 27m tests between March and end of July....
...The Covid-19 vaccine developed by BioNTech and Pfizer is likely to be effective against a rapidly spreading strain of the virus that was first discovered in the UK, a laboratory-based study by the companies...
...As such, the results bolster previous laboratory findings that the jab is highly effective against the B.1.1.7 strain....
...But transplants are limited by the supply of donor organs, and existing LVAD technologies marketed by Abbott Laboratories and Medtronic often lead to complications....
...Dean Li, president of Merck research laboratories, said the company remained “resolute in our commitment to contribute to the global effort to relieve the burden of this pandemic on patients, healthcare...
...They require specialist medical staff to perform them and laboratory equipment to analyse them. They are also expensive....
...Since Prof McNaughton moved to King’s in 2013, his laboratory has been looking for chemicals that block the activity of HCN2....
...Inge dubs it the new “clean-clinical”, while The Future Laboratory calls it “bio-positive”. Consumers are already voting this way with their wallets....
...Mr Adiri says smaller partners such as laboratories or imaging companies were concerned that the cloud services Google was trying to sell them looked too good to be true....
...These cells are now being tested in clinical trials; cells taken from a patient’s own bloodstream are matured into macrophages in the laboratory and then reinfused back into a patient with chronic liver...
...Car-T involves extracting a patient’s blood cells and re-engineering them in a laboratory so they can attack cancer, before infusing them back into the body....
...on its laboratory shelves....
...There are plenty of others, including St Jude Medical (acquired by Abbott Laboratories in January of this year), which is currently battling lawsuits relating to vulnerabilities in its implantable cardiac...
...More immediately, it is aiming to produce facsimiles of human tissue for use in clinical and cosmetic testing. L’Oréal is already using its technology....
...But the therapy is complex and expensive, with a process that involves extracting a patient’s blood cells in hospital, transporting the plasma — normally by air — to a laboratory, and re-engineering them...
...Will a move from the laboratory bench to the boardroom table improve returns for shareholders?...
...The latter denotes a bespoke drug manufactured specifically for an individual patient, like Novartis’ chimeric antigen receptor therapy (Car-T), which re-engineers a patient’s cells in a laboratory so they...
International Edition